In the recent study, it was found that the decreased expression of uPAR in lung tissues of COVID-19 patients led to the increased level of uPA, which subsequently caused the upregulation of IL-6 and ACE2 expression and significantly promoted PF by inducing EMT of lung epithelial cells. The gene discussed is PLAU; the disease is COVID-19.